1 / 22

Paediatric Asthma

Paediatric Asthma. Maria Tracey Paediatric Pharmacist Jane Davis Paediatric Clinical Nurse Specialist CF/Respiratory Royal Alexandra Hospital Paisley. Objectives. Explain the stepwise approach to the treatment of chronic asthma in children

paprika
Télécharger la présentation

Paediatric Asthma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Paediatric Asthma Maria Tracey Paediatric Pharmacist Jane Davis Paediatric Clinical Nurse Specialist CF/Respiratory Royal Alexandra Hospital Paisley

  2. Objectives • Explain the stepwise approach to the treatment of chronic asthma in children • Demonstrate the choice of inhaler devices used in children • Demonstrate multidosing

  3. Statistics • 5.2 million people in UK • 1.1 million children

  4. What is Asthma? Asthma is a condition of the airways wherethere is difficulty in breathing due to Inflammation Swelling Excess mucus • Or a combination of all three

  5. Asthma Triggers • Infections (eg colds and viruses) • House-dust mite • Pets (furred / feathered) • Second hand smoke • Exercise • Pollens/moulds

  6. Night cough, disturbed nights Restriction in activity / exercise Increased school absences Ongoing symptoms may have a detrimental effect on physical, psychological and social well-being The Impact of Asthma

  7. Children age 5-12 yrs

  8. Children age 5-12 yrs

  9. Children age 5-12 yrs

  10. Children age 5-12 yrs

  11. Children age 5-12 yrs

  12. Children age 5-12 yrs

  13. Combination Inhalers • Steroid/LABA • Can improve compliance • Useful when asthma stable • Lack of flexibility to  or  dose

  14. Key Points • Dose equivalence of corticosteroids • CFC free corticosteroid inhalers • Accurate medication history

  15. Asthma Medications • Relievers • Preventers • Additional Treatments

  16. Easyhaler

  17. Overview: Inhaler devices • pMDI + spacer is preferred delivery method in children aged 0-5 years • pMDI + spacer is as effective as other delivery methods for other age groups • Choice of inhaler should be based on patient preference and ability to use Inhaler devices. Thorax 2003; 58 (Suppl I): i1-i92

  18. Multidosing • Multiple puffs(up to 10) of a short-acting ß2 agonist via a spacer device is as effective as nebulised • Children(and adults) with mild and moderate exacerbation of asthma should be treated by bronchodilator given from a pMDI + spacer with doses titrated according to clinical response

  19. Summary: Paediatric asthma • Inhaled steroids are the recommended preventer drug • In children >5 years, add inhaled long acting ß2 agonists rather than increasing the dose of inhaled steroids above 400mcg/day • pMDI + spacer is preferred delivery method in children aged0-5 years, and as effective as other delivery methods for other age groups

  20. References • www.Asthma.Org.Uk Tel 02077865000 • British Thoracic Society, Scottish Intercollegiate guidelines Network (2008) British Guideline on the Management of Asthma Thorax (63) Supplement 1V

More Related